Arbor Pharmaceuticals, Inc. announced today the company has entered into an agreement with Campbell University's Pharmaceutical Sciences Institute to develop Arbor's latest product. Through this collaboration, Campbell University's experts in pharmaceutical product development will initiate a program to develop a novel formulation for ear infections in children.
Raleigh, NC (PRWEB) October 12, 2007 -- Arbor Pharmaceuticals, Inc. announced today the company has entered into an agreement with Campbell University's Pharmaceutical Sciences Institute to develop Arbor's latest product. Through this collaboration, Campbell University's experts in pharmaceutical product development will initiate a program to develop a novel formulation for ear infections in children. This agreement represents the first such collaboration between Arbor and Campbell, and the development project is currently underway.
"Arbor is pleased to be working with Campbell's Pharmaceutical Sciences Institute on this important product development project. By initiating this development work on our second product, Arbor continues to expand our pediatric product portfolio aimed at treating the most common childhood illnesses. With Campbell's development capabilities and pharmaceutical industry expertise, we are confident this project will help to bring another important product to pediatricians and their patients," says Jarrett Disbrow, President & Chief Executive Officer of Arbor Pharmaceuticals, Inc.
According to Dr. William Stagner, PhD, the Director of Campbell University's Pharmaceutical Sciences Institute, "this pharmaceutical development project will leverage Campbell's unique in-house expertise and deliver real clinical value in assisting this growing specialty pharmaceutical company. Campbell is glad to have Arbor as a partner, and we look forward to bringing our collective industry and academic experiences to Arbor Pharmaceuticals as they bring another therapy to market."
About Arbor Pharmaceuticals
Arbor Pharmaceuticals is a Raleigh, North Carolina based specialty pharmaceutical company focused on the licensing, development, and commercialization of products for pediatricians. Founded in 2006,
Arbor actively seeks out unique, patent-protected therapies proven to effectively treat common pediatric illnesses. Arbor Pharmaceuticals collaborates with pharmaceutical development companies and established promotional partners in the pharmaceutical industry to develop and market their products in order to serve the needs of pediatricians throughout the US.
To learn more about Arbor Pharmaceuticals, visit www.arborpharma.com or send email inquiries to info(@)arborpharma.com.
About Campbell University Pharmaceutical Sciences Institute
CUPSI is a pharmaceutical contracting organization, which provides quality research, development and small-scale production services at a competitive price to the pharmaceutical and biotechnology industries. CUPSI functions under the Campbell University system within the Pharmacy Research Facility. Campbell students with a major in Pharmaceutical Sciences are provided with a hands-on approach to education, preparing them as a future workforce in the pharmaceutical industry.